CJC-1295 with DAC vs MK-677 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
CJC-1295 with DAC is a long-acting GHRH analog that uses a Drug Affinity Complex (DAC) technology - a reactive maleimidoproprionic acid linker that covalently bonds to plasma albumin after injection. This albumin binding dramatically extends its half-life to 6-8 days, allowing on...
Calculate CJC-1295 with DAC dose →MK-677 (ibutamoren) is an orally active, non-peptide ghrelin receptor agonist (GHS-R1a) that stimulates GH release from the pituitary without requiring injection. It was developed by Merck and advanced through Phase II trials for growth hormone deficiency, muscle wasting, and fra...
Calculate MK-677 dose →| Parameter | CJC-1295 with DAC | MK-677 |
|---|---|---|
| Category | Growth Hormone & IGF | Growth Hormone & IGF |
| Research | Research Use | Phase II (Discontinued) |
| Half-Life | 6–8 days | ~24 hours |
| Typical Dose | 1,000–2,000 µg | 10–25 mg |
| Frequency | Once or twice weekly | Once daily |
| Route | Subcutaneous | Oral |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.